Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Ventilator-Associated Events: Prevalence, Outcome, and Relationship with Ventilator-Associated Pneumonia
Critical Care Medicine, Volume 43, No. 9, Year 2015
Notification
URL copied to clipboard!
Description
Centers for Disease Control and Prevention built up new surveillance paradigms for the patients on mechanical ventilation and the ventilator-associated events, comprising ventilator-associated conditions and infection-related ventilator-associated complications. We assess 1) the current epidemiology of ventilator-associated event, 2) the relationship between ventilator-associated event and ventilator-associated pneumonia, and 3) the impact of ventilator-associated event on antimicrobials consumption and mechanical ventilation duration. Design: Inception cohort study from the longitudinal prospective French multicenter OUTCOMEREA database (1996-2012). Patients: Patients on mechanical ventilation for greater than or equal to 5 consecutive days were classified as to the presence of a ventilator-associated event episode, using slightly modified Centers for Disease Control and Prevention definitions. Intervention: None. Measurements and Main Results: Among the 3,028 patients, 2,331 patients (77%) had at least one ventilator-associated condition, and 869 patients (29%) had one infection-related ventilator-associated complication episode. Multiple causes, or the lack of identified cause, were frequent. The leading causes associated with ventilator-associated condition and infection-related ventilator-associated complication were nosocomial infections (27.3% and 43.8%), including ventilator-associated pneumonia (14.5% and 27.6%). Sensitivity and specificity of diagnosing ventilator-associated pneumonia were 0.92 and 0.28 for ventilator-associated condition and 0.67 and 0.75 for infection-related ventilator-associated complication, respectively. A good correlation was observed between ventilator-associated condition and infection-related ventilator-associated complication episodes, and ventilator-associated pneumonia occurrence: R2 = 0.69 and 0.82 (p < 0.0001). The median number of days alive without antibiotics and mechanical ventilation at day 28 was significantly higher in patients without any ventilator-associated event (p < 0.05). Ventilator-associated condition and infection-related ventilator-associated complication rates were closely correlated with antibiotic use within each ICU: R2 = 0.987 and 0.99, respectively (p < 0.0001). Conclusions: Ventilator-associated event is very common in a population at risk and more importantly highly related to antimicrobial consumption and may serve as surrogate quality indicator for improvement programs. © 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.
Authors & Co-Authors
Bouadma, Lila
France, Paris
Inserm
France, Paris
Université Paris Cité
France, Paris
Ap-hp Assistance Publique - Hopitaux de Paris
Garrouste-Orgeas, Maïté
France, Paris
Inserm
France, Paris
Groupe Hospitalier Paris Saint-joseph
Darmon, Michaël
France, Saint-etienne
Université Jean Monnet Saint Etienne
Souweine, Bertrand
France, Clermont-ferrand
Hopital Gabriel Montpied
Kallel, Hatem
France, Cayenne
Cayenne General Hospital
Schwebel, Carole
France, Grenoble
Centre Hospitalier Universitaire de Grenoble
Dumenil, Anne Sylvie
France, Paris
Ap-hp Assistance Publique - Hopitaux de Paris
Argaud, Laurent
France, Lyon
Hopital Edouard Herriot
Ruckly, Stéphane
France, La Tronche
Albert Bonniot Institute Iab: Ontogenesis and Molecular Oncogenesis
Jamali, Samir
Unknown Affiliation
Adrie, Christophe
Unknown Affiliation
Lucet, Jean Christophe
France, Paris
Inserm
France, Paris
Université Paris Cité
France, Paris
Ap-hp Assistance Publique - Hopitaux de Paris
Azoulay, Elie
France, Paris
Université Paris Cité
France, Paris
Ap-hp Assistance Publique - Hopitaux de Paris
Timsit, Jéan-François Franc¸ois
France, Paris
Inserm
France, Paris
Université Paris Cité
France, Paris
Ap-hp Assistance Publique - Hopitaux de Paris
Statistics
Citations: 108
Authors: 14
Affiliations: 11
Identifiers
Doi:
10.1097/CCM.0000000000001091
ISSN:
00903493
Research Areas
Health System And Policy
Study Design
Randomised Control Trial
Cross Sectional Study
Cohort Study
Study Approach
Quantitative